Evidence map›Paper›PMID 22039245›Full record

ArticleInvestigative ophthalmology & visual science2011

A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine.

Kazunori Yamamoto, Kee Dong Yoon, Keiko Ueda, Masaru Hashimoto, Janet R Sparrow

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Quantitative fundus autofluorescence in healthy eyes.Investigative ophthalmology & visual science · 2013
    Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A five-year follow-up ofMolecular vision · 2022
    Article
  10. Review
  11. Fundus autofluorescence imaging.Progress in retinal and eye research · 2021
    Review
  12. Review
  13. Review
  14. Effects of deficiency in theThe Journal of biological chemistry · 2020
    Article
  15. Lessons learned from quantitative fundus autofluorescence.Progress in retinal and eye research · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kazunori YamamotoDepartment of Ophthalmology, Columbia University, 630 W. 168th Street, New York, NY 10032, USA.
Kee Dong Yoon
Keiko Ueda
Masaru Hashimoto
Janet R Sparrow
Columbia University · USHirosaki University · JP

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
IMPACT OF LIPOFUSCIN IN RETINAL PIGMENT EPITHELIAL CELLSR01EY012951 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPARROW, JANET RUTHE · 2000 to 2024
$8.9M
NEI NIH HHS EY12951NEI NIH HHS P30 EY019007NEI NIH HHS P30EY019007NEI NIH HHS R01 EY012951
6 · The paper itself

Abstract

purposeFluorescent bisretinoid compounds accumulate in retinal pigment epithelial (RPE) cells as a consequence of two processes: random reactions of vitamin A aldehyde in photoreceptor cell outer segments, and phagocytosis of discarded photoreceptor outer segment discs by RPE. The formation of bisretinoid is accentuated in some forms of retinal degeneration. The detection of a novel bisretinoid fluorophore that is a conjugate of all-trans-retinal and glycerophosphoethanolamine is reported.

methodsHuman RPE/choroid, eyes harvested from Abca4 (ATP-binding cassette transporter 4) null mutant mice, and biosynthetic reaction mixtures were analyzed by ultra performance liquid chromatography coupled to mass spectrometry and by nuclear magnetic resonance spectra and spectrofluorometry.

resultsA fluorescent compound in mouse eyes and in human RPE/choroid corresponded to the product of the reaction between all-trans-retinal and glycerophosphoethanolamine (A2-GPE), as determined on the basis of molecular weight (m/z 746), absorbance (approximately 338,443 nm), and retention time. Nuclear magnetic resonance spectra were consistent with a pyridinium molecule with a glycerophosphate moiety. The emission maximum of A2-GPE was approximately 610 nm. A2-GPE accumulated with age in mouse eyes and was more abundant in Abca4(-/-) mice, a model of recessive Stargardt disease.

conclusionsTo date, several bisretinoids of RPE lipofuscin have been isolated and characterized, and for all of these, formation involves the membrane phospholipid phosphatidylethanolamine. Conversely, the bisretinoid A2-GPE is detected as sn-glycero-3-phosphoethanolamine (GPE) derivatized by two all-trans-retinal. The pathways by which A2-GPE may form under conditions of increased availability of all-trans-retinal, for instance in the Abca4(-/-) mouse, are discussed.

Indexed as

AnimalsATP-Binding Cassette TransportersChromatography, High Pressure LiquidDisease Models, AnimalDiterpenesHumansLipofuscinMacular DegenerationMagnetic Resonance SpectroscopyMass SpectrometryMiceMice, KnockoutPhosphatidylethanolaminesPyridinium CompoundsRetinaRetinaldehydeA2-PE compoundABCA4 protein, humanATP-Binding Cassette TransportersDiterpenesglycerophosphoethanolamineLipofuscinPhosphatidylethanolaminesPyridinium CompoundsRetinaldehydeRetinoidsVitamin Avitamin A-aldehyde-dihydropyridine-phosphatidylethanolamine

Identifiers

PMID22039245
PMCPMC3231846
OpenAlexW1997925124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.